中华结核和呼吸杂志
中華結覈和呼吸雜誌
중화결핵화호흡잡지
Chinese Journal of Tuberculosis and Respiratory Diseases
2012年
7期
520-523
,共4页
程璘令%刘雅雅%李冰%李时悦%冉丕鑫
程璘令%劉雅雅%李冰%李時悅%冉丕鑫
정린령%류아아%리빙%리시열%염비흠
抗坏血酸%正黏病毒科%体外研究
抗壞血痠%正黏病毒科%體外研究
항배혈산%정점병독과%체외연구
Ascorbic acid%Orthomyxoviridae%In vitro
目的 探讨药理剂量维生素C体外杀灭流感病毒A/CA/7/09 (H1N12009)的作用及其机制.方法 将流感病毒A/CA/7/09感染人类正常呼吸道上皮细胞(NHBE)后,立即或8h后分别加入2.5~20 mmol/L维生素C、维生素C+过氧化氢酶和不含维生素C的NHBE培养基,或直接在流感病毒A/CA/7/09中分别加入上述培养基.培养4~12 h后,分别收集培养基上清液,通过半数组织培养感染剂量( TCID50)法对病毒进行定量检测.利用高压液相层析法(HPLC)测量样品中维生索C含量和Clark型氧电极法测量样品中过氧化氢浓度.结果 药理剂量的维生素C可杀灭体外游离的流感病毒,也能杀灭体外培养细胞内的流感病毒;维生素C杀灭病毒的效应与剂量相关:2.5 mmol/L的维生素C可杀灭约90%的流感病毒,20 mmol/L的维生素C可杀灭所有病毒;维生素C在病毒感染不同时间窗的杀灭病毒效应不同,在病毒感染8~12h内,维生素C杀灭病毒的效果最好;4 h内可清除感染NHBE细胞的所有流感病毒;感染后期维生素C杀灭病毒的效果最差.维生素C杀灭病毒的效应可被过氧化氧酶完全抑制.结论 药理剂量的维生素C作为一种强氧化剂,可能通过生成过氧化氢发挥杀灭细胞内外流感病毒的作用.
目的 探討藥理劑量維生素C體外殺滅流感病毒A/CA/7/09 (H1N12009)的作用及其機製.方法 將流感病毒A/CA/7/09感染人類正常呼吸道上皮細胞(NHBE)後,立即或8h後分彆加入2.5~20 mmol/L維生素C、維生素C+過氧化氫酶和不含維生素C的NHBE培養基,或直接在流感病毒A/CA/7/09中分彆加入上述培養基.培養4~12 h後,分彆收集培養基上清液,通過半數組織培養感染劑量( TCID50)法對病毒進行定量檢測.利用高壓液相層析法(HPLC)測量樣品中維生索C含量和Clark型氧電極法測量樣品中過氧化氫濃度.結果 藥理劑量的維生素C可殺滅體外遊離的流感病毒,也能殺滅體外培養細胞內的流感病毒;維生素C殺滅病毒的效應與劑量相關:2.5 mmol/L的維生素C可殺滅約90%的流感病毒,20 mmol/L的維生素C可殺滅所有病毒;維生素C在病毒感染不同時間窗的殺滅病毒效應不同,在病毒感染8~12h內,維生素C殺滅病毒的效果最好;4 h內可清除感染NHBE細胞的所有流感病毒;感染後期維生素C殺滅病毒的效果最差.維生素C殺滅病毒的效應可被過氧化氧酶完全抑製.結論 藥理劑量的維生素C作為一種彊氧化劑,可能通過生成過氧化氫髮揮殺滅細胞內外流感病毒的作用.
목적 탐토약리제량유생소C체외살멸류감병독A/CA/7/09 (H1N12009)적작용급기궤제.방법 장류감병독A/CA/7/09감염인류정상호흡도상피세포(NHBE)후,립즉혹8h후분별가입2.5~20 mmol/L유생소C、유생소C+과양화경매화불함유생소C적NHBE배양기,혹직접재류감병독A/CA/7/09중분별가입상술배양기.배양4~12 h후,분별수집배양기상청액,통과반수조직배양감염제량( TCID50)법대병독진행정량검측.이용고압액상층석법(HPLC)측량양품중유생색C함량화Clark형양전겁법측량양품중과양화경농도.결과 약리제량적유생소C가살멸체외유리적류감병독,야능살멸체외배양세포내적류감병독;유생소C살멸병독적효응여제량상관:2.5 mmol/L적유생소C가살멸약90%적류감병독,20 mmol/L적유생소C가살멸소유병독;유생소C재병독감염불동시간창적살멸병독효응불동,재병독감염8~12h내,유생소C살멸병독적효과최호;4 h내가청제감염NHBE세포적소유류감병독;감염후기유생소C살멸병독적효과최차.유생소C살멸병독적효응가피과양화양매완전억제.결론 약리제량적유생소C작위일충강양화제,가능통과생성과양화경발휘살멸세포내외류감병독적작용.
Objective To investigate the effects and mechanism of pharmacological ascorbate against Influenza A/CA/7/09 ( H1N12009).Methods NHBE cells ( ≈95% confluent monolayer) in 12-well plates (Corning) were kept at 37 ℃ at all times. NHBE cells were exposed to A/CA/7/09(H1N12009) influenza virus at MOI of 0.01 for 1 h,rinsed with NHBE medium,and incubated with NHBE medium containing 20 mmol/L ascorbate or 20 mmol/L ascorbate + 600 IU/ml Catalase.The cells were then incubated for an additional 4 - 12 h and the culture medium was harvested for titration.Viral titers were determined as log10 50% tissue culture infective doses ( TCID50 ) assay in MDCK cells.Ascorbate in NHBE medium was determined using HPLC separation coupled with coulometric electrochemical detection.Hydrogen peroxide was detected indirectly by Clark-type oxygen electrode.Results In vitro experiments showed that pharmacological ascorbate killed not only isolated viruses,but also viruses from normal human bronchial epithelial cells.The antiviral effect of ascorbic acid appeared to be dose-dependent.2.5 mmol/Lascorbic acid was able to eliminate 90% of the viruses and 20 mmol/L ascorbic acid totally blocked viral replication in vitro.The antiviral effect of pharmacological ascorbate varied at different phases of infection.Pharmacological ascorbate eliminated viral infectivity with treatment times as short as 4 hours at early stage of infection.But the effect was reversed by catalase.Conclusion Pharmacological ascorbate ( vitamin C) as a pro-drug eliminates or kills influenza virus,probable by producing steady-state concentrations of hydrogen peroxide ( H2O2 ) in extracellular fluid.